Aaron Cowen Suvretta Capital Management
Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$102M |
| 2 |
SHPG
Shire pic
SHPG
|
+$59.3M |
| 3 |
McDonald's
MCD
|
+$59.1M |
| 4 |
NXP Semiconductors
NXPI
|
+$54.4M |
| 5 |
Bausch Health
BHC
|
+$54.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$84.2M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$67.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$58.7M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$57.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.66% |
| 2 | Technology | 13.9% |
| 3 | Materials | 11.83% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Five Below
FIVE
$13.8B
| $18.5M | 1.1% |
+521,000
| New | +$17.4M |
|
27
CALL
Yum! Brands
YUM
$41.8B
| $9.84M | 0.59% |
+173,875
| New | +$9.49M |
|
28
Energy Transfer Partners
ET
$73B
| $976K | 0.06% |
30,800
-1,600
| -5% | -$47.4K |
|
29
Blackstone
BX
$108B
| $797K | 0.05% |
20,890
-12,431
| -37% | -$449K |
|
|
30
PUT
Bausch Health
BHC
$2.41B
| – | – |
-50,000
| Closed | -$7.16M |
|
31
Carter's
CRI
$1.31B
| – | – |
-448,500
| Closed | -$39.2M |
|
32
Dollar General
DG
$27.2B
| – | – |
-360,500
| Closed | -$25.5M |
|
33
Dollar Tree
DLTR
$25.3B
| – | – |
-532,700
| Closed | -$37.5M |
|
34
Domino's
DPZ
$11.3B
| – | – |
-293,200
| Closed | -$27.6M |
|
35
Alphabet (Google) Class C
GOOG
$4.18T
| – | – |
-1,421,873
| Closed | -$37.6M |
|
|
36
Meta Platforms (Facebook)
META
$1.4T
| – | – |
-629,600
| Closed | -$49.1M |
|
|
37
Thermo Fisher Scientific
TMO
$233B
| – | – |
-468,500
| Closed | -$58.7M |
|
|
ENDP
38
CALL
DELISTED
Endo International plc
ENDP
| – | – |
-65,000
| Closed | -$4.69M |
|
|
ENDP
39
DELISTED
Endo International plc
ENDP
| – | – |
-792,300
| Closed | -$57.1M |
|
|
ANDV
40
CALL
DELISTED
Andeavor
ANDV
| – | – |
-123,000
| Closed | -$9.14M |
|
|
ANDV
41
DELISTED
Andeavor
ANDV
| – | – |
-476,600
| Closed | -$35.4M |
|
|
COV
42
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| – | – |
-659,500
| Closed | -$67.5M |
|
|
AGN
43
DELISTED
Allergan Inc
AGN
| – | – |
-396,300
| Closed | -$84.2M |
|
Similar funds
Aaron Cowen's Q1 2015 Portfolio in Review
As of Q1 2015, Aaron Cowen held 43 positions worth $1.68B, up 20% from $1.4B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Aaron Cowen deployed $169M of net new capital in Q1 2015, opening 14 new positions and adding to 9 existing holdings. Its largest new stake was Aramark: 4,450,698 shares worth $102M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 30% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was CDK Global, Inc., an estimated $15.7M trimmed.
- Aaron Cowen's largest Q1 2015 buy was Aramark: 4,450,698 shares worth $102M.
- Aaron Cowen added most to Corpay in Q1 2015, an estimated $33.7M increase.
- Aaron Cowen's biggest Q1 2015 reduction was CDK Global, Inc., cutting an estimated $15.7M.
- Aaron Cowen fully exited Allergan Inc in Q1 2015, selling an estimated $84.2M.
- Aaron Cowen's ten largest holdings make up 58% of its $1.68B portfolio in Q1 2015.
- Aaron Cowen opened 14 new positions and closed 14 in Q1 2015.
- Aaron Cowen's portfolio value rose 20% quarter-over-quarter to $1.68B.
Based on Suvretta Capital Management's 13F filing for Q1 2015, filed 15 May 2015.